Illumina Newswire (Page 2)

Illumina Newswire (Page 2)

Comprehensive Real-Time News Feed for Illumina. (Page 2)

Results 21 - 40 of 737 in Illumina

  1. Intercontinental Exchange (ICE) Holder Armstrong Shaw Associates...Read the original story

    Tuesday Feb 6 | Hill Country Times

    Intercontinental Exchange Holder Armstrong Shaw Associates Lowered Its Stake by $6.42 Million as Valuation Rose; Biondo Investment Advisors Has Trimmed Its Illumina Stake by $316,012; Share Price Rose Biondo Investment Advisors Llc decreased its stake in Illumina Inc by 3.51% based on its latest 2017Q3 regulatory filing with the SEC. Biondo Investment Advisors Llc sold 1,588 shares as the company's stock rose 8.35% with the market.

    Comment?

  2. EPS for Triangle Capital (TCAP) Expected At $0.34; Jabre Capital...Read the original story w/Photo

    Tuesday Feb 6 | Hill Country Times

    ... February 6, 2017 and is uptrending. It has underperformed by 14.34% the S&P500. Jabre Capital Partners Sa decreased Illumina Inc (ILMN) stake by 33.33% reported in 2017Q3 SEC filing. Jabre Capital Partners Sa sold 8,000 shares as Illumina Inc ...

    Comment?

  3. Illumina (ILMN) Lowered to "Hold" at BidaskClubRead the original story w/Photo

    Tuesday Feb 6 | IntersportsWire

    ILMN has been the topic of a number of other reports. Deutsche Bank set a $275.00 price target on shares of Illumina and gave the company a buy rating in a report on Tuesday, January 16th.

    Comment?

  4. Illumina (ILMN) Rating Increased to Buy at CitigroupRead the original story w/Photo

    Monday Feb 5 | AmericanBankingNews.com

    ... Jaffray Companies restated an "overweight" rating and set a $226.00 price target (up from $202.00) on shares of Illumina in a report on Monday, October 9th. Canaccord Genuity restated a "buy" rating and set a $230.00 price target (up from $215.00) ...

    Comment?

  5. Charles Dadswell Sells 1,610 Shares of Illumina, Inc. (ILMN) StockRead the original story w/Photo

    Monday Feb 5 | AmericanBankingNews.com

    Illumina, Inc. SVP Charles Dadswell sold 1,610 shares of the business's stock in a transaction on Monday, February 5th. The shares were sold at an average price of $221.45, for a total transaction of $356,534.50.

    Comment?

  6. A Blaine Bowman Sells 3,000 Shares of Illumina, Inc. (ILMN) StockRead the original story w/Photo

    Monday Feb 5 | IntersportsWire

    Illumina, Inc. Director A Blaine Bowman sold 3,000 shares of the business's stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $230.82, for a total transaction of $692,460.00.

    Comment?

  7. Illumina, Inc. (ILMN) Position Trimmed by Kidder Stephen WRead the original story w/Photo

    Monday Feb 5 | IntersportsWire

    Kidder Stephen W trimmed its holdings in shares of Illumina, Inc. by 2.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,946 shares of the life sciences company's stock after selling 385 shares during the period.

    Comment?

  8. Financial Review: IlluminaRead the original story w/Photo

    Sunday Feb 4 | AmericanBankingNews.com

    Illumina and ResMed are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation. Illumina has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

    Comment?

  9. Brokerages Expect Illumina, Inc. (ILMN) Will Post Quarterly Sales of $741.34 MillionRead the original story w/Photo

    Sunday Feb 4 | Daily Political

    Wall Street analysts forecast that Illumina, Inc. will post $741.34 million in sales for the current fiscal quarter, according to Zacks . Six analysts have provided estimates for Illumina's earnings.

    Comment?

  10. Illumina (ILMN) Upgraded to "Overweight" by First AnalysisRead the original story w/Photo

    Sunday Feb 4 | IntersportsWire

    First Analysis currently has $277.00 price target on the life sciences company's stock. First Analysis also issued estimates for Illumina's Q1 2018 earnings at $1.09 EPS, Q2 2018 earnings at $1.10 EPS, FY2018 earnings at $4.55 EPS and FY2019 earnings at $5.29 EPS.

    Comment?

  11. Illumina, Inc. (ILMN) Given Average Recommendation of "Buy" by AnalystsRead the original story w/Photo

    Saturday Feb 3 | IntersportsWire

    Shares of Illumina, Inc. have received an average recommendation of "Buy" from the twenty-four ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and thirteen have issued a buy recommendation on the company.

    Comment?

  12. Illumina (ILMN) Downgraded by BidaskClub to HoldRead the original story w/Photo

    Saturday Feb 3 | AmericanBankingNews.com

    Several other research analysts also recently weighed in on ILMN. First Analysis upgraded Illumina from an "equal weight" rating to an "overweight" rating and set a $277.00 target price on the stock in a research note on Wednesday.

    Comment?

  13. Illumina (ILMN) PT Raised to $215.00Read the original story w/Photo

    Saturday Feb 3 | IntersportsWire

    ... Companies restated an overweight rating and set a $226.00 target price (up previously from $202.00) on shares of Illumina in a research report on Monday, October 9th. Canaccord Genuity restated a buy rating and set a $230.00 target price (up ...

    Comment?

  14. Illumina (ILMN) Stock Rating Lowered by BidaskClubRead the original story w/Photo

    Friday Feb 2 | Daily Political

    ILMN has been the subject of several other reports. Barclays increased their target price on shares of Illumina from $150.00 to $185.00 and gave the company an "equal weight" rating in a research note on Wednesday, October 25th.

    Comment?

  15. Illumina, Inc. to Post Q1 2018 Earnings of $1.04 Per Share, William Blair ForecastsRead the original story w/Photo

    Friday Feb 2 | AmericanBankingNews.com

    Equities researchers at William Blair issued their Q1 2018 earnings per share estimates for shares of Illumina in a research note issued to investors on Wednesday. William Blair analyst A. Murphy expects that the life sciences company will post earnings of $1.04 per share for the quarter.

    Comment?

  16. Illumina, Inc. (ILMN) to Post Q1 2018 Earnings of $0.88 Per Share, Leerink Swann ForecastsRead the original story w/Photo

    Friday Feb 2 | AmericanBankingNews.com

    Equities researchers at Leerink Swann lowered their Q1 2018 earnings per share estimates for Illumina in a research report issued on Wednesday. Leerink Swann analyst P. Souda now anticipates that the life sciences company will post earnings of $0.88 per share for the quarter, down from their prior estimate of $1.08.

    Comment?

  17. Illumina (ILMN) PT Raised to $276.00Read the original story w/Photo

    Friday Feb 2 | IntersportsWire

    ... indicates a potential upside of 19.85% from the company's current price. Leerink Swann also issued estimates for Illumina's Q1 2018 earnings at $0.88 EPS, Q2 2018 earnings at $1.06 EPS, Q3 2018 earnings at $1.26 EPS, Q4 2018 earnings at $1.37 EPS, ...

    Comment?

  18. Cullen Frost Bankers Inc. Cuts Stake in Illumina, Inc.Read the original story w/Photo

    Friday Feb 2 | IntersportsWire

    Cullen Frost Bankers Inc. lessened its position in shares of Illumina, Inc. by 5.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,619 shares of the life sciences company's stock after selling 412 shares during the quarter.

    Comment?

  19. Illumina, Inc. (ILMN) Position Decreased by Howland Capital Management LLCRead the original story w/Photo

    Thursday Feb 1 | The Breeze

    Howland Capital Management LLC cut its holdings in shares of Illumina, Inc. by 10.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,760 shares of the life sciences company's stock after selling 550 shares during the quarter.

    Comment?

  20. Leerink Swann Research Analysts Reduce Earnings Estimates for Illumina, Inc.Read the original story w/Photo

    Thursday Feb 1 | AmericanBankingNews.com

    Stock analysts at Leerink Swann lowered their Q2 2018 earnings estimates for Illumina in a report issued on Wednesday. Leerink Swann analyst P. Souda now anticipates that the life sciences company will post earnings per share of $1.06 for the quarter, down from their prior forecast of $1.14.

    Comment?